Renal dysfunction improving drug comprising optical isomer of 1,4-benzothiazepine-1-oxide derivative
US11844803B2 · kind B2 · utility
0Cited by
2References
5Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | Dec 11, 2018 |
| Grant date | Dec 19, 2023 |
| Priority date | — |
| Expiry date | Dec 11, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P13/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention addresses the problem of providing a pharmaceutical composition for treatment of a variety of conditions accompanied by renal dysfunction.Renal dysfunction is improved by a pharmaceutical composition that comprises an optical isomer of a 1,4-benzothiazepine-1-oxide derivative represented by general formula [II]
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.